Statins, risk of diabetes, and implications on outcomes in the general population

Journal of the American College of Cardiology

Volumn 60, Issue 14, 2012, Pages 1231-1238

  Wang, Kang Ling ^a,b   Liu, Chia Jen ^a   Chao, Tze Fan ^a,b   Huang, Chi Ming ^a,b   Wu, Cheng Hsueh ^a,b   Chen, Su Jung ^a,b   Chen, Tzeng Ji ^a,b   Lin, Shing Jong ^a,b   Chiang, Chern En ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

diabetes; outcome research; statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SECONDARY PREVENTION;

AGED; CASE-CONTROL STUDIES; COHORT STUDIES; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STROKE; TREATMENT OUTCOME;

EID: 84866733914     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.05.019     Document Type: Article

References (32)

1. C. Baigent, A. Keech, P.M. Kearney Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
2. C. Baigent, L. Blackwell, J. Emberson Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials Lancet 376 2010 1670 1681
3. J. Armitage The safety of statins in clinical practice Lancet 370 2007 1781 1790 (Pubitemid 350137473)
4. K.M. Dale, C.I. Coleman, N.N. Henyan, J. Kluger, C.M. White Statins and cancer risk: a meta-analysis JAMA 295 2006 74 80 (Pubitemid 43042692)
5. D.J. Freeman, J. Norrie, N. Sattar Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study Circulation 103 2001 357 362 (Pubitemid 32105973)
6. P.M. Ridker, E. Danielson, F.A. Fonseca Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
7. S. Yusuf, E. Lonn, J. Bosch Lipid lowering for primary prevention Lancet 373 2009 1152 1155
8. N. Sattar, D. Preiss, H.M. Murray Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials Lancet 375 2010 735 742
9. D.D. Waters, J.E. Ho, D.A. DeMicco Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials J Am Coll Cardiol 57 2011 1535 1545
10. D. Preiss, S.R. Seshasai, P. Welsh Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis JAMA 305 2011 2556 2564
11. J.L. Mehta Statins and altered glucose metabolism: a laboratory curiosity or a new disease? J Am Coll Cardiol 56 2010 680 author reply 680-1
12. S.M. Grundy, J.I. Cleeman, C.N. Merz Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines J Am Coll Cardiol 44 2004 720 732
13. V. de Groot, H. Beckerman, G.J. Lankhorst, L.M. Bouter How to measure comorbidity a critical review of available methods J Clin Epidemiol 56 2003 221 229 (Pubitemid 36513483)
14. C.L. Cheng, Y.H. Kao, S.J. Lin, C.H. Lee, M.L. Lai Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan Pharmacoepidemiol Drug Saf 20 2011 236 242
15. C.C. Lin, M.S. Lai, C.Y. Syu, S.C. Chang, F.Y. Tseng Accuracy of diabetes diagnosis in health insurance claims data in Taiwan J Formos Med Assoc 104 2005 157 163 (Pubitemid 44524953)
16. C.H. Chang, W.Y. Shau, Y.D. Jiang Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999-2004: a national health insurance data set study Diabet Med 27 2010 636 643
17. G. Maskarinec, E. Erber, A. Grandinetti Diabetes incidence based on linkages with health plans: the multiethnic cohort Diabetes 58 2009 1732 1738
18. J. Sasaki, M. Iwashita, S. Kono Statins: beneficial or adverse for glucose metabolism J Atheroscler Thromb 13 2006 123 129
19. A.L. Culver, I.S. Ockene, R. Balasubramanian Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative Arch Intern Med 172 2012 144 152
20. H.S. Kim, Y. Wu, S.J. Lin Current status of cholesterol goal attainment after statin therapy among patients with hypercholesterolemia in Asian countries and region: the Return on Expenditure Achieved for Lipid Therapy in Asia (REALITY-Asia) study Curr Med Res Opin 24 2008 1951 1963
21. G.H. Gislason, J.N. Rasmussen, S.Z. Abildstrom Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction Eur Heart J 27 2006 1153 1158
22. V. Salomaa, R. Paakkonen, H. Hamalainen, M. Niemi, T. Klaukka Use of secondary preventive medications after the first attack of acute coronary syndrome Eur J Cardiovasc Prev Rehabil 14 2007 386 391 (Pubitemid 46945561)
23. L. Wei, S. Ebrahim, C. Bartlett, P.D. Davey, F.M. Sullivan, T.M. MacDonald Statin use in the secondary prevention of coronary heart disease in primary care: cohort study and comparison of inclusion and outcome with patients in randomised trials BMJ 330 2005 821
24. M. Nakata, S. Nagasaka, I. Kusaka, H. Matsuoka, S. Ishibashi, T. Yada Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control Diabetologia 49 2006 1881 1892 (Pubitemid 44025043)
25. L.H. Chamberlain Inhibition of isoprenoid biosynthesis causes insulin resistance in 3T3-L1 adipocytes FEBS Lett 507 2001 357 361 (Pubitemid 33030265)
26. R. Sukhija, S. Prayaga, M. Marashdeh Effect of statins on fasting plasma glucose in diabetic and nondiabetic patients J Investig Med 57 2009 495 499
27. K.K. Koh, I. Sakuma, M.J. Quon Differential metabolic effects of distinct statins Atherosclerosis 215 2011 1 8
28. L. Masana Pitavastatin - from clinical trials to clinical practice Atheroscler Suppl 11 2010 15 22
29. W.L. Baker, R. Talati, C.M. White, C.I. Coleman Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis Diabetes Res Clin Pract 87 2010 98 107
30. R.W. Nesto Correlation between cardiovascular disease and diabetes mellitus: current concepts Am J Med 116 Suppl 5A 2004 11S 22S (Pubitemid 38333037)
31. L.D. Lazar, M.J. Pletcher, P.G. Coxson, K. Bibbins-Domingo, L. Goldman Cost-effectiveness of statin therapy for primary prevention in a low-cost statin era Circulation 124 2011 146 153
32. J. Betteridge Pitavastatin - results from phase III & IV Atheroscler Suppl 11 2010 8 14